Correction: Real‑world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC‑FFM in ruxolitinib‑refractory acute graft‑versus‑host disease
Halvard Bonig, Mareike Verbeek, Peter Herhaus, Krischan Braitsch, Gernot Beutel, Christoph Schmid, Nadine Müller, Gesine Bug, Michaela Döring, Arend von Stackelberg, Johanna Tischer, Francis Ayuk, Gerald Wulf, Udo Holtick, Lisa‑Marie Pfeffermann, Bernd Jahrsdörfer
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMesenchymal stem cell research · Hematopoietic Stem Cell Transplantation · Periodontal Regeneration and Treatments
**Correction: Journal of Translational Medicine (2023) 21:837 ** 10.1186/s12967-023-04731-1
Following publication of the original article [1], we have been notified that the author’s last name was published incorrectly.
It is now:
Krischan Braitssch
It should be:
Krischan Braitsch
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Bonig H Verbeek M Herhaus P Braitsch K Beutel G Schmid CMüller N Bug GDöring Mvon Stackelberg A Tischer J Ayuk F Wulf G Holtick U Pfeffermann L-M Jahrsdörfer B Schrezenmeier H Kuci S Zens A Tribanek M Zeiser R Huenecke S Bader P Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease J Transl Med 20232183710.1186/s 12967-023-04731-137990219 PMC 10664468 · doi ↗ · pubmed ↗